Evidence map›Paper›PMID 42492317›Full record

ArticleClinics (Sao Paulo, Brazil)2026

Glasgow coma scale-pupils at 24-hours as a reliable marker for extremely poor prognosis in traumatic brain injury - A prospective cohort.

Pedro Fortes Osório Bustamante, Roberta Muriel Longo Roepke, Filipe Matheus Cadamuro, Francisco Falleiros de Mello, Bárbara Vieira Carneiro, Brasil Chian Ping Jeng, Wellingson Silva Paiva, Sérgio Henrique Bastos Damous, Edivaldo Massazo Utiyama, Estevão Bassi

Abstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pedro Fortes Osório BustamanteDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil. Electronic address: pfortes7@gmail.com.
Roberta Muriel Longo RoepkeDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Intensive Care Unit, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Filipe Matheus CadamuroDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Francisco Falleiros de MelloDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Bárbara Vieira CarneiroDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Intensive Care Unit, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Brasil Chian Ping JengDepartment of Neurosurgery, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Wellingson Silva PaivaDepartment of Neurosurgery, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Sérgio Henrique Bastos DamousDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Edivaldo Massazo UtiyamaDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Estevão BassiDepartment of Surgery, Division of General Surgery and Trauma, Hospital das Clinicas HCMFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Intensive Care Unit, Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEarly prognosis determination after traumatic brain injury remains challenging, yet reliable early markers remain limited. A Glasgow Coma Scale-Pupil (GCS-P) score of 1, combining a GCS of 3 and bilaterally nonreactive pupils, has been proposed as a marker of catastrophic injury, although some patients may recover. The authors hypothesized that persistence of a GCS-P score of 1 after 24 h could predict poor prognosis.

methodsDescriptive study in a quaternary ICU in Brazil, including adult patients admitted between 2019 and 2025 with a pre-sedation GCS of 3 and bilaterally nonreactive pupils. Patients with unknown initial neurological status or a Marshall Computed Tomography Classification < 3 were excluded. Clinical characteristics, imaging findings, treatments, and outcomes were prospectively collected. The primary outcome was the Glasgow Outcome Scale-Extended (GOSE) at hospital discharge.

resultsAmong 2645 ICU admissions, 868 were due to TBI, and 49 met the inclusion criteria. Patients were predominantly young (median age 38-years), male (79.6%), and had high illness severity (median SAPS3 of 68). Most suffered blunt trauma, and nearly half underwent hemicraniectomy. All patients who persisted with a GCS-P score of 1 after 24-hours died during hospitalization (n = 36, 95% CI 90.3%-100%). Among those who improved their GCS-P score within 24-hours (n = 13), mortality was 54% (95% CI 25.1%-80.8%), and 31% (95% CI 9.1%-61.4%) recovered consciousness (GOSE > 2).

conclusionPersistence of a GCS-P score of 1 after 24-hours is a highly reliable marker of poor prognosis in patients with severe TBI. These findings warrant external validation.

Indexed as

Brain DeathGlasgow coma scale pupils scoreIntensive CareNeuroprognosticationTraumatic brain injury

Identifiers

PMID42492317
PMCPMC13427555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.